448 related articles for article (PubMed ID: 8452322)
1. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.
Ravid M; Savin H; Jutrin I; Bental T; Katz B; Lishner M
Ann Intern Med; 1993 Apr; 118(8):577-81. PubMed ID: 8452322
[TBL] [Abstract][Full Text] [Related]
2. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.
Ravid M; Brosh D; Levi Z; Bar-Dayan Y; Ravid D; Rachmani R
Ann Intern Med; 1998 Jun; 128(12 Pt 1):982-8. PubMed ID: 9625684
[TBL] [Abstract][Full Text] [Related]
3. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
Ravid M; Lang R; Rachmani R; Lishner M
Arch Intern Med; 1996 Feb; 156(3):286-9. PubMed ID: 8572838
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
Chan JC; Ko GT; Leung DH; Cheung RC; Cheung MY; So WY; Swaminathan R; Nicholls MG; Critchley JA; Cockram CS
Kidney Int; 2000 Feb; 57(2):590-600. PubMed ID: 10652036
[TBL] [Abstract][Full Text] [Related]
5. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.
Ahmad J; Siddiqui MA; Ahmad H
Diabetes Care; 1997 Oct; 20(10):1576-81. PubMed ID: 9314638
[TBL] [Abstract][Full Text] [Related]
6. Long-term effect of ACE inhibition on development of nephropathy in diabetes mellitus type II.
Ravid M; Savin H; Jutrin I; Bental T; Lang R; Lishner M
Kidney Int Suppl; 1994 Feb; 45():S161-4. PubMed ID: 8158887
[TBL] [Abstract][Full Text] [Related]
7. Effects of long-term enalapril treatment on persistent microalbuminuria in normotensive type 2 diabetic patients: results of a 4-year, prospective, randomized study.
Sano T; Hotta N; Kawamura T; Matsumae H; Chaya S; Sasaki H; Nakayama M; Hara T; Matsuo S; Sakamoto N
Diabet Med; 1996 Feb; 13(2):120-4. PubMed ID: 8641115
[TBL] [Abstract][Full Text] [Related]
8. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.
Marre M; Chatellier G; Leblanc H; Guyene TT; Menard J; Passa P
BMJ; 1988 Oct; 297(6656):1092-5. PubMed ID: 2848604
[TBL] [Abstract][Full Text] [Related]
9. Persistent albuminuria in normotensive non-insulin-dependent (type II) diabetic patients: comparative effects of angiotensin-converting enzyme inhibitors and beta-adrenoceptor blockers.
Stornello M; Valvo EV; Scapellato L
Clin Sci (Lond); 1992 Jan; 82(1):19-23. PubMed ID: 1310913
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin converting enzyme inhibition in normotensive type II diabetics with persistent mild proteinuria.
Stornello M; Valvo EV; Scapellato L
J Hypertens Suppl; 1989 Dec; 7(6):S314-5. PubMed ID: 2561147
[TBL] [Abstract][Full Text] [Related]
11. Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy.
Heinemann L; Janicke I; Bender R; Berger M; Sawicki PT
Horm Metab Res; 1996 Oct; 28(10):549-52. PubMed ID: 8934214
[TBL] [Abstract][Full Text] [Related]
12. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
Laffel LM; McGill JB; Gans DJ
Am J Med; 1995 Nov; 99(5):497-504. PubMed ID: 7485207
[TBL] [Abstract][Full Text] [Related]
13. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes.
Schrier RW; Estacio RO; Esler A; Mehler P
Kidney Int; 2002 Mar; 61(3):1086-97. PubMed ID: 11849464
[TBL] [Abstract][Full Text] [Related]
14. Plasma lipids and the progression of nephropathy in diabetes mellitus type II: effect of ACE inhibitors.
Ravid M; Neumann L; Lishner M
Kidney Int; 1995 Mar; 47(3):907-10. PubMed ID: 7752591
[TBL] [Abstract][Full Text] [Related]
15. Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin dependent diabetes.
Hallab M; Gallois Y; Chatellier G; Rohmer V; Fressinaud P; Marre M
BMJ; 1993 Jan; 306(6871):175-82. PubMed ID: 8443481
[TBL] [Abstract][Full Text] [Related]
16. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.
Andersen S; Tarnow L; Rossing P; Hansen BV; Parving HH
Kidney Int; 2000 Feb; 57(2):601-6. PubMed ID: 10652037
[TBL] [Abstract][Full Text] [Related]
17. [Urinary albumin excretion in non-insulin-dependent diabetic patients. Effects of an angiotensin-converting enzyme inhibitor].
Durruty P; Tapia JC; Ugarte C; Pérez E; Krause P; Soto N; García de los Ríos M
Rev Med Chil; 1996 Sep; 124(9):1036-44. PubMed ID: 9197016
[TBL] [Abstract][Full Text] [Related]
18. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
Lewis EJ; Lewis JB
Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
[TBL] [Abstract][Full Text] [Related]
19. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.
Crepaldi G; Carta Q; Deferrari G; Mangili R; Navalesi R; Santeusanio F; Spalluto A; Vanasia A; Villa GM; Nosadini R
Diabetes Care; 1998 Jan; 21(1):104-10. PubMed ID: 9538979
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.
Barnett AH; Bain SC; Bouter P; Karlberg B; Madsbad S; Jervell J; Mustonen J;
N Engl J Med; 2004 Nov; 351(19):1952-61. PubMed ID: 15516696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
